| Gene ID | 9 |
| Symbol | NAT1 |
| Synonymous | AAC1|MNAT|NAT-1|NATI |
| Full name | N-acetyltransferase 1 (arylamine N-acetyltransferase) |
| Gene description | N-acetyltransferase type 1|arylamide acetylase 1|arylamine N-acetyltransferase 1|monomorphic arylamine N-acetyltransferase |
| Cytoband | 8p22 |
| Gene type | protein-coding |
| Synonymous | MIM:108345; HGNC:HGNC:7645; Ensembl:ENSG00000171428; HPRD:00149; Vega:OTTHUMG00000097001 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Drug metabolism - other enzymes;KEGG PATHWAY;hsa00983 |
Pathway | Acetylation;PID Reactome;500214 |
Pathway | Caffeine metabolism;KEGG PATHWAY;hsa00232 |
Pathway | Metabolic pathways;KEGG PATHWAY;hsa01100 |
Pathway | Biological oxidations;Reactome;REACT:13433 |
Disease | Lupus erythematosus;FunDO |
Disease | Spinal dysraphism;FunDO |
Disease | von Hippel-Lindau tumour;GAD |
Disease | prostate cancer;GAD |
Disease | mild and severe substance abuse;GAD |
Disease | lung cancer;GAD |
Disease | IMMUNE;GAD |
Disease | breast cancer;GAD |
Disease | urinary bladder cancer;GAD |
Disease | increased chromosome aberrations and higher lung cancer risk;GAD |
Disease | Cleft palate;FunDO |
Disease | CANCER;GAD |
Disease | Cancer;FunDO |
Disease | higher N-acetylation activity;GAD |
Disease | bladder cancer;GAD |
Disease | Asthma;GAD |
Disease | Contact Allergy;GAD |
Disease | Hepatitis;GAD |
Disease | Ulcerative colitis;FunDO |
Disease | Parkinson disease;FunDO |
Disease | colorectal cancer;GAD |
Sequence Information | |
|---|---|
Nucleotide Sequence | >9 : length: 2468 ACTTTGGAAGTGAGAGCACTTCCTCATAGACCTTGGATGTGGGAGGATTGCATTCAGTCTAGTTCCTGGTTGCCGGCTGAAATAACCTGACCGAGAGCATCACCCCCTGAACATGGACTT GCAGAATTCCACAGAAGAGAGGAGACTGGCCTAGACAGACAGCCCCAGGAGCTGAGGGCCCAACAGGCTTTCTACCCTGGATGCTGCTCCCATGCCCTGACATGAGGCCCACTACAATGC TCTCCAAAATGTCCACAAAAGTGACTTAAGTCAGGTTCCCCCAAACCAGACACCAAGACAAGAATCCATGTGTGTGTGACTGAAGGAAGTGCTGGGAGAGCCCCAGCTGCAGCCTGGATG TGAACTGCAACTCCAAAGTGTGTCCAGACTCAAGGCAAGGGCACTAGGCTTTCCAGACCTCCTACTAAGTCATTGATCCAGCACTGCCCTGCCAGGACATAAATCCCTGGCACCTCTTGC TCTCTGCAAAGGAGGGCAAAGCAGCTTCAGGAGCCCTTGGGAGTCCTCCAAAGAGAGTCTAGGGTACAGGTCCGAAAGTAGAAGAACACAGAAGGCAGGCCAGGGGCACTGTGAGATGGT AAAAGAGATCTGAAGGGATCCAGACGTGTACAGAAGGGCCATGCTGTTATTACTCTTACACAAGGAGGCAGCCCTCGAGCCACAGGGTCCAGCTGTTGGCTATAATAGCCTACCGGTCTC TGATGATCACCATGTTTCTGGAATTCAAGCCAGGAAGAAGCAGCAATCTGTCTTCTGGATTAAAACTGAAGATCAACCTACTTTCAACTTACTAAGAAAGGGGATCATGGACATTGAAGC ATATCTTGAAAGAATTGGCTATAAGAAGTCTAGGAACAAATTGGACTTGGAAACATTAACTGACATTCTTCAACACCAGATCCGAGCTGTTCCCTTTGAGAACCTTAACATCCATTGTGG GGATGCCATGGACTTAGGCTTAGAGGCCATTTTTGATCAAGTTGTGAGAAGAAATCGGGGTGGATGGTGTCTCCAGGTCAATCATCTTCTGTACTGGGCTCTGACCACTATTGGTTTTGA GACCACGATGTTGGGAGGGTATGTTTACAGCACTCCAGCCAAAAAATACAGCACTGGCATGATTCACCTTCTCCTGCAGGTGACCATTGATGGCAGGAACTACATTGTCGATGCTGGGTT TGGACGCTCATACCAGATGTGGCAGCCTCTGGAGTTAATTTCTGGGAAGGATCAGCCTCAGGTGCCTTGTGTCTTCCGTTTGACGGAAGAGAATGGATTCTGGTATCTAGACCAAATCAG AAGGGAACAGTACATTCCAAATGAAGAATTTCTTCATTCTGATCTCCTAGAAGACAGCAAATACCGAAAAATCTACTCCTTTACTCTTAAGCCTCGAACAATTGAAGATTTTGAGTCTAT GAATACATACCTGCAGACATCTCCATCATCTGTGTTTACTAGTAAATCATTTTGTTCCTTGCAGACCCCAGATGGGGTTCACTGTTTGGTGGGCTTCACCCTCACCCATAGGAGATTCAA TTATAAGGACAATACAGATCTAATAGAGTTCAAGACTCTGAGTGAGGAAGAAATAGAAAAAGTGCTGAAAAATATATTTAATATTTCCTTGCAGAGAAAGCTTGTGCCCAAACATGGTGA TAGATTTTTTACTATTTAGAATAAGGAGTAAAACAATCTTGTCTATTTGTCATCCAGCTCACCAGTTATCAACTGACGACCTATCATGTATCTTCTGTACCCTTACCTTATTTTGAAGAA AATCCTAGACATCAAATCATTTCACCTATAAAAATGTCATCATATATAATTAAACAGCTTTTTAAAGAAACATAACCACAAACCTTTTCAAATAATAATAATAATAATAATAAAAAATGT ATTTTAAAGATGGCCTGTGGTTATCTTGGAAATTGGTGATTTATGCTAGAAAGCTTTTAATGTTGGTTTATTGTTGAATTCCTAGAAAAGTTTTATTGGTAGATGAGTAAATAAAATATT GTAAAAAAACTTATTGTCTATAAAGTATATTAAAACATTGTTGGCTAATATAATTTGAAAAAAAGTGGTTTTTTGGAAGACTTAGGATATTATGGTGCTACATAATTTTTCCTCGATGCT CTCTTCCTCTCATCTTTCTTGTCTCTTAAATTACTTTACTTCCTTGCACACTTTGCCATACAAGAATGAACATGAGCTTTTCTTGTGTAGATCTGAGTTGAAATCCTGTGGACACTGGGC GAATTACTTTTTAGATCTGTAGCTCTGACTCCTCAGGCATAAAATGGGAATAATGCTTTTACAGTTTAGTGGCGGAACTAAACTCCCAAAATTATTTGTTATATGGATCAAGTAATAACG TCAGTAATGTTTTTGGTACAAAGTCATTATTTAATAAAAGTTATTGTTCCATCTTGCTTGCCCCCCCA |
Protein Sequence | >9 : length: 352 MLLLLLHKEAALEPQGPAVGYNSLPVSDDHHVSGIQARKKQQSVFWIKTEDQPTFNLLRKGIMDIEAYLERIGYKKSRNKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQ VVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGFGRSYQMWQPLELISGKDQPQVPCVFRLTEENGFWYLDQIRREQYIPNEEFLHS DLLEDSKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRRFNYKDNTDLIEFKTLSEEEIEKVLKNIFNISLQRKLVPKHGDRFFTI |